Detalhe da pesquisa
1.
Optimizing the dose in patients treated with imatinib as first line treatment for gastrointestinal stromal tumours: A cost-effectiveness study.
Br J Clin Pharmacol
; 85(9): 1994-2001, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31112617